Previous reports have shown that AS1517499, a STAT6 inhibitor, has the ability to hinder M2 polarization in vitro, which subsequently leads to a decrease in the tumor growth rates and metastasis in a 4T1 mammary carcinoma model [38]. Here, STAT6 is linked to breast carcinoma.